However, mice that received CD4 T cells from ITI-3000-immunized IFNγ-/- mice showed tumor kinetics and overall survival equivalent to that of mice that received CD4 T cells from control-immunized mice (Figures 6B, C). The gene discussed is CD4; the disease is neoplasm.